Variant report
Variant | nsv969372 |
---|---|
Chromosome Location | chr6:29541332-29542549 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR2H5P | TF binding region |
TMEM183AP1 | TF binding region |
ENSG00000231301 | chromatin interactions |
ENSG00000201330 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563228021 | chr6:29541338-29541339 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs6912437 | chr6:29541394-29541395 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs190448319 | chr6:29541406-29541407 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs150941133 | chr6:29541443-29541444 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs527956907 | chr6:29541446-29541447 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs78950938 | chr6:29541455-29541456 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs571151518 | chr6:29541465-29541466 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs539449782 | chr6:29541493-29541494 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs556564379 | chr6:29541507-29541508 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs569774914 | chr6:29541524-29541525 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs144722395 | chr6:29541551-29541552 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs555106512 | chr6:29541557-29541558 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs72507814 | chr6:29541566-29541567 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs74374220 | chr6:29541574-29541575 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs374602326 | chr6:29541580-29541581 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs557764464 | chr6:29541630-29541631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs577909578 | chr6:29541631-29541632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs543008621 | chr6:29541702-29541703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563274982 | chr6:29541711-29541712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528970206 | chr6:29541746-29541747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541172977 | chr6:29541749-29541750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs559524215 | chr6:29541766-29541767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs527865247 | chr6:29541821-29541822 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548019230 | chr6:29541833-29541834 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
25 | rs181761095 | chr6:29541846-29541847 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112925600 | chr6:29541877-29541878 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533688997 | chr6:29541895-29541896 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
28 | rs549862501 | chr6:29541897-29541898 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
29 | rs138633183 | chr6:29541910-29541911 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
30 | rs115684491 | chr6:29541930-29541931 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184481188 | chr6:29541947-29541948 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565880601 | chr6:29541951-29541952 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
33 | rs534508170 | chr6:29541999-29542000 | Weak transcription Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
34 | rs188933608 | chr6:29542021-29542022 | Bivalent Enhancer Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
35 | rs72507815 | chr6:29542064-29542065 | Bivalent Enhancer Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs141758982 | chr6:29542078-29542079 | Bivalent Enhancer Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs112888634 | chr6:29542091-29542092 | Bivalent Enhancer Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs556963369 | chr6:29542161-29542162 | Bivalent Enhancer Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
39 | rs573666191 | chr6:29542183-29542184 | Bivalent Enhancer Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
40 | rs112248026 | chr6:29542215-29542216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541228273 | chr6:29542233-29542234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564708449 | chr6:29542238-29542239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs111355711 | chr6:29542263-29542264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550155804 | chr6:29542274-29542275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs542384283 | chr6:29542282-29542283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs117342586 | chr6:29542295-29542296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs563664826 | chr6:29542343-29542344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs529244226 | chr6:29542369-29542370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs113117124 | chr6:29542421-29542422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549003734 | chr6:29542424-29542425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 19571809 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21509527 | CNVD |
Melanoma | 17363583 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:29541200-29553200 | Weak transcription | H9 Cell Line | embryonic stem cell |
2 | chr6:29541800-29542000 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr6:29541800-29542200 | ZNF genes & repeats | Spleen | Spleen |
4 | chr6:29542000-29542200 | Bivalent Enhancer | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr6:29542200-29545200 | Weak transcription | Spleen | Spleen |